de Macedo M, Glanzner W, Gutierrez K, Currin L, Rissi V, Baldassarre H
J Assist Reprod Genet. 2025; .
PMID: 40025368
DOI: 10.1007/s10815-025-03437-1.
Farrokhi Yekta R, Farahani M, Koushki M, Amiri-Dashatan N
Front Oncol. 2024; 14:1481426.
PMID: 39497715
PMC: 11532047.
DOI: 10.3389/fonc.2024.1481426.
Wang J, Zhang R, Wu C, Wang L, Liu P, Li P
Front Pharmacol. 2024; 15:1432724.
PMID: 39431155
PMC: 11486755.
DOI: 10.3389/fphar.2024.1432724.
Hassanzadeh K, Liu J, Maddila S, Mouradian M
Pharmacol Rev. 2024; 76(6):1254-1290.
PMID: 39164116
PMC: 11549938.
DOI: 10.1124/pharmrev.123.001111.
Kobayashi E, Shaul Lotan N, Schejter Y, Makowski C, Kraus V, Ramchandar N
J Pediatr. 2024; 274:114180.
PMID: 38972567
PMC: 11556246.
DOI: 10.1016/j.jpeds.2024.114180.
Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells.
Huang C, Yang T, Lin K
J Biomed Sci. 2024; 31(1):16.
PMID: 38280996
PMC: 10821541.
DOI: 10.1186/s12929-024-01003-y.
SUMOylation of Bonus, the homolog of Transcription Intermediary Factor 1, safeguards germline identity by recruiting repressive chromatin complexes to silence tissue-specific genes.
Godneeva B, Ninova M, Fejes-Toth K, Aravin A
Elife. 2023; 12.
PMID: 37999956
PMC: 10672805.
DOI: 10.7554/eLife.89493.
Nuclear transport proteins: structure, function, and disease relevance.
Yang Y, Guo L, Chen L, Gong B, Jia D, Sun Q
Signal Transduct Target Ther. 2023; 8(1):425.
PMID: 37945593
PMC: 10636164.
DOI: 10.1038/s41392-023-01649-4.
Identification of Natural Products as SENP2 Inhibitors for Targeted Therapy in Heart Failure.
Taghvaei S, Sabouni F, Minuchehr Z
Front Pharmacol. 2022; 13:817990.
PMID: 35431915
PMC: 9012495.
DOI: 10.3389/fphar.2022.817990.
The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells.
Shi X, Du Y, Li S, Wu H
Int J Mol Sci. 2022; 23(7).
PMID: 35408996
PMC: 8998487.
DOI: 10.3390/ijms23073639.
(De)Activation (Ir)Reversibly or Degradation: Dynamics of Post-Translational Protein Modifications in Plants.
Muleya V, Lois L, Chahtane H, Thomas L, Chiapello M, Marondedze C
Life (Basel). 2022; 12(2).
PMID: 35207610
PMC: 8874572.
DOI: 10.3390/life12020324.
SUMOylation Is Associated with Aggressive Behavior in Chondrosarcoma of Bone.
Kroonen J, Kruisselbrink A, Briaire-de Bruijn I, Olaofe O, Bovee J, Vertegaal A
Cancers (Basel). 2021; 13(15).
PMID: 34359724
PMC: 8345166.
DOI: 10.3390/cancers13153823.
Modulation of the Interactions Between α-Synuclein and Lipid Membranes by Post-translational Modifications.
Bell R, Vendruscolo M
Front Neurol. 2021; 12:661117.
PMID: 34335440
PMC: 8319954.
DOI: 10.3389/fneur.2021.661117.
SUMOylation- and GAR1-Dependent Regulation of Dyskerin Nuclear and Subnuclear Localization.
MacNeil D, Lambert-Lanteigne P, Qin J, McManus F, Bonneil E, Thibault P
Mol Cell Biol. 2021; 41(4).
PMID: 33526451
PMC: 8088130.
DOI: 10.1128/MCB.00464-20.
Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation.
Alquezar C, Arya S, Kao A
Front Neurol. 2021; 11:595532.
PMID: 33488497
PMC: 7817643.
DOI: 10.3389/fneur.2020.595532.
RNF11 at the Crossroads of Protein Ubiquitination.
Mattioni A, Castagnoli L, Santonico E
Biomolecules. 2020; 10(11).
PMID: 33187263
PMC: 7697665.
DOI: 10.3390/biom10111538.
Genetic alteration and clinical significance of SUMOylation regulators in multiple cancer types.
Wu G, Xu Y, Ruan N, Li J, Lv Q, Zhang Q
J Cancer. 2020; 11(23):6823-6833.
PMID: 33123273
PMC: 7592005.
DOI: 10.7150/jca.49042.
The Role of Sumoylation in the Response to Hypoxia: An Overview.
Filippopoulou C, Simos G, Chachami G
Cells. 2020; 9(11).
PMID: 33114748
PMC: 7693722.
DOI: 10.3390/cells9112359.
The requirement of SUMO2/3 for SENP2 mediated extraembryonic and embryonic development.
Yu H, Hsu T, Maruyama E, Paschen W, Yang W, Hsu W
Dev Dyn. 2019; 249(2):237-244.
PMID: 31625212
PMC: 7027852.
DOI: 10.1002/dvdy.125.
SUMOlock reveals a more complete Aspergillus nidulans SUMOylome.
Horio T, Szewczyk E, Oakley C, Osmani A, Osmani S, Oakley B
Fungal Genet Biol. 2019; 127:50-59.
PMID: 30849444
PMC: 6673660.
DOI: 10.1016/j.fgb.2019.03.002.